Sign Out
Pregnancy: There are limited amounts of data from the use of ceftazidime in pregnant women.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.
Ceftazidime should be prescribed to pregnant woman only if the benefit outweighs the risk.
Lactation: Ceftazidime is excreted in human milk in small quantities but at therapeutic doses of ceftazidime no effects on the breast-fed infant are anticipated. Ceftazidime can be used during breast-feeding.
Continue with Google